India Pitches Phased Pharma Market Entry to Russia During Putin Visit

• India proposed a phased entry plan for its pharmaceutical firms into the Russian and Eurasian markets during President Putin's visit.
• The plan aims to ease market-entry barriers and strengthen supply chains, aligning with Russia's 'Russia 2030' policy for local production.
• India suggested pilot collaborations, joint inspections, and GMP recognition exercises to build trust and facilitate market access.
• Successful pilot companies could gain simplified registration and preferential access to the EAEU market over five years.
• Despite Russia being a major pharma importer, India's current market share is small, indicating significant growth potential.

Why It Matters: India's pharma sector eyes major growth in the Russian market.